Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ElenaN
    Junior Member
    • Nov 2012
    • 8

    Filtering steps for VarScan2 somatic and germline calls

    What is the proper filtering pipeline for somatic mutation detection using VarScan2, with tumor/normal paired samples?
    My understanding of the steps:
    0. VarScan2 somatic to make calls
    Then filter:
    1. VarScan2 processSomatic to separte calls Germline/Somatic/LOH and call some "high confidence"
    2. VarScan2 somaticFilter on the Somatic.hc file to do further filtering.
    - as I understand, this is where filtering for false positives aroudn indels take place
    - it also seems to look at p-values and such - is it not redundant with the previous step?
    3. fpfilter.pl on the resulting data for further filtering?
    (in my hands this step seems to hang indefinitely without doing anything, though. not sure why)

    My questions are:
    - is this a correct order of steps, or are some of the 3 filtering steps redundant or obsolete?
    - what are the recommended parameter settings for bam-read-count, especially mapping quality q? Should it be 1, as is recommended for mpileup, or higher?

    Now, if I want to detect germline mutations in the same sample, can I just use the "Germline" (and I guess LOH) calls from VarScan?
    Dan Koboldt seems to think so, as long as one uses the normal bamcount in step 3. Should "VarScan2 filter" be used in step 2? Or should a separate germline mutation caller be used for this purpose?

    Thank you,
    Elena
  • dkoboldt
    Member
    • Mar 2009
    • 62

    #2
    Elena,

    You could probably just perform steps 1 and 3 and get a good high-confidence set of somatic mutation calls.... the somaticFilter command is more simplistic than the filter false positives.

    If you want the germline calls, combine Germline.hc and LOH.hc files, and then run that through the false positive filter with the NORMAL bam.

    As for bam-readcount, I'd recommend at least mapping quality of 1 and base quality of 15.

    Comment

    • ElenaN
      Junior Member
      • Nov 2012
      • 8

      #3
      Thanks, Dan!
      (BTW, I just posted another VarScan question as a separate thread http://seqanswers.com/forums/showthr...364#post109364 - it'd be really great if you could answer it as well.)

      Comment

      • zhixiang
        Junior Member
        • Oct 2012
        • 2

        #4
        Originally posted by dkoboldt View Post
        Elena,

        You could probably just perform steps 1 and 3 and get a good high-confidence set of somatic mutation calls.... the somaticFilter command is more simplistic than the filter false positives.

        If you want the germline calls, combine Germline.hc and LOH.hc files, and then run that through the false positive filter with the NORMAL bam.

        As for bam-readcount, I'd recommend at least mapping quality of 1 and base quality of 15.
        Hi dkoboldt,

        Can filterfp.pl be used to filter the somatic indels?

        Can I combine the indel vcf and snp vcf from the output of varscan somatic, and then filter the vcf file using step 1 and step 3? Does this works for both snp and indel in the vcf file?

        Comment

        • thek71
          Junior Member
          • Mar 2011
          • 4

          #5
          Hi all,
          I have a similar question regarding the germline mutations. I have several tumor-normal samples for which I have used the somatic command and I want to check several genes for germline mutations. From the publication is stated that hc variants are the ones with at least 10% allele frequency in normal and tumor samples.
          This varinat is in the hc file:
          chr1 565088 C T 0 37 100% T 4 19 82.61% T Germline 1.0 0.018159073897484498 2 2 10 9 0 0 22 15
          while this one
          chr1 741267 T C 33 38 53.52% Y 30 22 42.31% Y Germline 5.540944545408712E-23 0.9211526256316275 2 28 3 19 10 23 5
          33
          is not. The numbers of reads and the percentages seem to be ok, but I fail to understand why the variants are categorized differently.
          Any help would be highly appreciated.

          Thank you in advance

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          29 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          211 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          78 views
          0 reactions
          Last Post SEQadmin2  
          Working...